動物向け疼痛管理の世界市場 2023年：医薬品 (NSAID・オピオイド)・装置・関節痛 (変形性関節症・筋骨格障害)・術後疼痛・癌
Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023
|出版日||ページ情報||英文 239 Pages
|動物向け疼痛管理の世界市場 2023年：医薬品 (NSAID・オピオイド)・装置・関節痛 (変形性関節症・筋骨格障害)・術後疼痛・癌 Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023|
|出版日: 2018年04月20日||ページ情報: 英文 239 Pages||
世界の動物向け疼痛管理市場は、2018年の11億3,000万米ドルから2023年までに16億6,000万米ドルに達すると予測され、この間は8.0%のCAGR (複合年間成長率) が見込まれています。コンパニオンアニマル飼育の増加、先進経済諸国における獣医師数とその所得水準の増加、痛み・炎症をもたらす動物疾患の有病率の増加、および動物医療費の上昇によるペット保険の加入増加は、動物向け疼痛管理市場の成長を促進すると予測されています。しかし、ペットケアコストの増大は、同市場の成長をある程度抑制する可能性があります。
"Global veterinary pain management market projected to grow at a CAGR of 8.0%"
The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal diseases causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care cost may restrain market growth to a certain extent.
On the basis of devices, the market is segmented into laser and electromagnetic therapy devices. Laser therapy devices accounted for the largest share of the veterinary pain management devices market. The large share of this segment can be attributed to the effectiveness of laser therapy devices in curing a wide range of acute and chronic pain conditions in animals.
On the basis of application, the market is segmented into joint pain, postoperative pain, cancer, and other applications. The cancer segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing prevalence of cancer in companion animals and the requirement of pain management at every stage of cancer treatment.
By animal type, the market is further segmented into companion and livestock. In 2017, the companion animals segmented accounted for the largest share of the veterinary pain management market due to increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure.
North America dominated the veterinary pain management market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. In North America, the US is expected to hold the largest share of the veterinary pain management market due to the growing number of people adopting pets, increasing animal healthcare expenditure, growing veterinary practices, and increasing prevalence of chronic diseases such as cancer and osteoarthritis.
Break of primary participants was as mentioned below:
The major players in the veterinary pain management market are: Zoetis(US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Sante Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK).
The veterinary pain management market in this report is segmented by product, application, animal type, distribution channel, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, new product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the veterinary pain management market.
From an insight perspective, this research report has focused on various levels of analysis-market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the veterinary pain management market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest veterinary pain industry statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.
The report provides insights on the following pointers:
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.